| Tag | Content |
|---|
EnhancerAtlas ID | HS012-14603 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr17:41162270-41163320 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2A | MA0052.3 | chr17:41162688-41162700 | GCTAAAAATAGA | + | 6.92 | | MEF2B | MA0660.1 | chr17:41162688-41162700 | GCTAAAAATAGA | + | 6.44 | | MEF2C | MA0497.1 | chr17:41162686-41162701 | CTGCTAAAAATAGAA | + | 7.06 | | POU4F2 | MA0683.1 | chr17:41162619-41162635 | ATGAATAACTAATGAT | + | 6.23 | | Zfx | MA0146.2 | chr17:41163295-41163309 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35535 | chr17:41161771-41164515 | HepG2 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 41162878 | 41163074 | | chr17 | 41162308 | 41162387 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I043010 | chr17 | 41162142 | 41164362 |
|
Enhancer Sequence | AATAGCTGGC ATGATGGCAC ACGCCTGTAC TCAGGAGGCT GAGATGAGAG GATTGATTGA 60
TTCCAGGAGG TCGAGGCTGC AGTGAGCCAT AATGGAGCAA TTGCACTCCA GCCTGGGTGG 120
CATTGAGACT TTGTCTCAAA AAACAAAACA AAACAAAAAC ATGGGTAGAT TTGCTGTGGG 180
GGGAAACTTT GTTATGGCTA GAAGCAGTTT ACTTTAGAAA GGACATGCTC TTCCCAGTGC 240
GTCAGAGTCC CCACCACTCT CTGTTATCCT ACATGGCTCT ATTAACTCAT TAATGTCATC 300
CAACTGGCCC TTAAAGGCAC TGTGTTAGCA CTCTCTGAGT TACAGAAATA TGAATAACTA 360
ATGATCTTTT TCACTATTCA TAAACCAGCA TAATTTGGTC AAGCTCTAGT ATTCTTCTGC 420
TAAAAATAGA ACAAACTCAC ACTGAATTTC TTTGGTGTCC TCTGTAATGT GCTCCTTTAC 480
CGTCATTCAT TCACTTCATT TCTTCATTCA ACACAGTTTT ACCGGACACA TATTTTGTGC 540
CGGAGATCTT GCTGGACACA AGGAATACAG AGATGGTCAG AACAGAGTCC TATCTTTCCA 600
AGAGATCTCA TGCTTCTCTG AGCTGAACTT CTTTATCAGG ATTCCTAACC ACAGGGTGAA 660
CTCTGCTCTA TTCCACAAAC AAAGGTGCAT TTATTGGTAT CCCTGGTGTC ACTTCCCTGC 720
CTGTGATGTC AGTTCTCTCT CTGGACCCAT TCCAGATCAC ACCCAGCCTA AAAGGTTACT 780
TGGTGTACAG TGGAAAGTGT GACAGTCCAG GGACAAGCTA GAATTGATGG GTAAACTACC 840
TCCCCACTCT GGGCTTCATT TCTTCACTGT AAAGCACAGG TTAGTGGGTG GGCTCTGGAG 900
TCAGACAGCC TAGGGCCAAA TGACTTTGGG CAAGTCATTT AACCTCTCTG AGCTTTAATT 960
TCCTCATCTA TAAAATAAGG ATTGGCCAGG CATTGTGGCT TACACCTGTA ATCCTAGCAC 1020
TTTAGGAGGC CGAGGCGGGC AGATCATCTG 1050
|
